Skip to content

Alphatec Holdings, Inc. (ATEC) Company Overview

Company Analysis

Alphatec Holdings, Inc. ATEC

A comprehensive view of key metrics, scores, and financial health for Alphatec Holdings, Inc.

Overview of Alphatec Holdings, Inc.

ATEC NMS
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Small Cap
Alphatec Holdings, Inc. (ATEC), is a Small Cap company, in the Medical Devices industry, last closed at $7.31, about 16.7% overvalued vs fair value, -62.5% 1Y return, ranked 450/1145 in sector.
Metrics Rev Growth 25.0% ROE 16440.1% Gross Margin 69.6%
USD 7.31
3.84%
(Delayed)
• Vol 90d: 100.5%
52-Week Range
Market Cap
$1.13B
Enterprise Value
$1.59B
Overall Score
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Completeness: 88%
Confidence: 92%
Updated: Oct 31
Top Beats

Quick Facts

HQ Carlsbad, CA
Employees 913
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$5
$6
$7
Current: $7.31 -17% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$764.2M
25%%
Gross Profit
$531.9M
25.4%%
Operating Income (GAAP)
-$82.1M
39.7%%
EBITDA
-$14.9M
72.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
69.6%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
6
Active Leaks
1/6
Improving
0
High Impact
6
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Alphatec Holdings, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
65
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Key strengths

  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 0.71). High FCF conversion confirms strong earnings quality.
  • Comfortable Interest Coverage Interest coverage quality is strong vs peers (score 0.68). Debt servicing capacity supports continued M&A optionality.

Key risks

  • Revenue Growth Slowing Revenue growth trend is weak (score 0.33). Slowing top-line momentum reduces the future consumable base.
  • Elevated Leverage Leverage is elevated vs peers (score 0.00). High net debt/EBITDA limits the balance sheet's acquisition firepower.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
68

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 79% Coverage
Trade-Off Triangle Visualization A ternary plot showing ATEC's balance between Growth (41.0%), Profitability (34.5%), and Safety (24.5%). Growth 41% Safety 25% Profitability 35%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

70th percentile vs peers
71
Key Signals
Rev Growth YoY 24.9% 82p Revenue CAGR 3Y 29.6% 82p EPS Growth YoY 15.8% 44p TSR 22.4% 71p Asset Growth YoY 2.0% 55p
  • Rev Growth YoY in top 20% of peers (24.9%, 82th percentile)
  • Revenue CAGR 3Y in top 20% of peers (29.6%, 82th percentile)
  • Growth above peer median with strong metric coverage (85%)

No significant risks identified for this axis.

Profitability

59th percentile vs peers
59
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

42th percentile vs peers
42
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Alphatec Holdings, Inc..

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$6.09
- - -
-16.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000